Insider · CIK 0001167426
John Neis
Files at CLRB (Cellectar Biosciences, Inc.). First filing Dec 16, 2025, latest Dec 16, 2025.
John Neis files SEC Form 4 as director at CLRB (Cellectar Biosciences, Inc.). Since Dec 16, 2025, John Neis has reported 0 open-market buys worth $0 and 1 open-market sell worth $732, the latest filed on Dec 16, 2025.
A track record needs three past buys with six months of prices behind them; John Neis has 0, so none is measured yet.
The newest scored trade: sold $732 of CLRB on Dec 12, 2025, filed Dec 16, 2025, scored 35 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $732.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLRB: Cellectar Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | CLRBsell Cellectar Biosciences, Inc. | $732 198 shares | -95% | +28% from low-74% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | CLRB Cellectar Biosciences, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -198 | $3.70 | $732 | 10 | Dec 16, 2025 |
| Feb 14, 2025 | CLRB Cellectar Biosciences, Inc. | AGrant or award Stock option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Feb 18, 2025 |
Questions about John Neis
Answered from the filings on this page, as of the latest one.
Is John Neis buying or selling?
In the last 12 months John Neis reported 0 open-market buys worth $0 and 1 open-market sell worth $732 on SEC Form 4; the latest was sold $732 of CLRB on Dec 12, 2025. Grants, option exercises and tax withholding are not counted.
How did John Neis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Neis has 0.
Where does John Neis file Form 4?
John Neis has filed Form 4 at CLRB (Cellectar Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.